Citation Impact
Citing Papers
Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c- MYC transcription
2002 Standout
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
2002 Standout
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity
2004 StandoutNobel
Antisense SCL suppresses self-renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562.
1991
Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1
2004 Standout
Role of Caspases, Bid, and p53 in the Apoptotic Response Triggered by Histone Deacetylase Inhibitors Trichostatin-A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA)
2003
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules
1993 StandoutNature
Cytokine- and T-helper-dependent immunity in murine aspergillosis
1998
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Expression of soluble guanylate cyclase activity requires both enzyme subunits
1991 StandoutNobel
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
2000
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
New light on Myc and Myb. Part I. Myc.
1990
Specific regulation of gene expression by antisense, sense and antigene nucleic acids
1990
The tumor suppressive properties of adeno-associated viruses
1994
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
Induction of apoptosis in fibroblasts by c-myc protein
1992 Standout
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
1992 StandoutNobel
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
2011 Standout
Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?
2001
Therapeutic Outcome in Invasive Aspergillosis
1996
The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development
1994 StandoutNobel
The Epigenomics of Cancer
2007 Standout
Effects of Macrophage Colony-Stimulating Factor on Antifungal Activity of Mononuclear Phagocytes against Aspergillus fumigatus
1995
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
2002 Standout
Histone deacetylases and cancer: causes and therapies
2001 Standout
Trends in the postmortem epidemiology of invasive fungal infections at a University Hospital
1996 Standout
Histone deacetylase as a therapeutic target
2001
Chromatin Modification, Leukaemia and Implications for Therapy
2002
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
An amino-acid taste receptor
2002 StandoutNature
Oligomerization of RAR and AML1 Transcription Factors as a Novel Mechanism of Oncogenic Activation
2000
New light on Myc and Myb. Part II. Myb.
1990
Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation
1999
Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties
1990
Histone deacetylases: silencers for hire
2000
Role of histone deacetylases in acute leukemia
1998
The hormone resistin links obesity to diabetes
2001 StandoutNature
Survival and Prognostic Factors of Invasive Aspergillosis After Allogeneic Bone Marrow Transplantation
1999
Pulmonary host defences against Aspergillus fumigatus
1998
Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes
1999
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
2001 Standout
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
2010
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Clinical pharmacokinetics of tyrosine kinase inhibitors
2009
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
2000 StandoutNature
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
2010 StandoutNature
Intracellular disposition and metabolism of fluorescently-labled unmodified and modified oligouncleotides microijjected into mammalian cells
1993
Control of c-myc Regulation in Normal and Neoplastic Cells
1991
Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb
1989 StandoutNobel
The Theory of APL Revisited
2007
Lyn and Fgr Protein-tyrosine Kinases Prevent Apoptosis during Retinoic Acid-induced Granulocytic Differentiation of HL-60 Cells
1996 StandoutNobel
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
Transcription therapy for cancer
2001
Molecular mechanisms of action of antisense drugs
1999
Histone Acetylation Modifiers in the Pathogenesis of Malignant Disease
2000
cdc2 Gene Expression at the G 1 to S Transition in Human T Lymphocytes
1990 Science
Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia.
2001
Proteasome regulation of activation-induced T cell death
1997 StandoutNobel
Regulation of fungal extracellular proteases and their role in mammalian pathogenesis
1995
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Transcription Factors, Normal Myeloid Development, and Leukemia
1997
Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon
1993
Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration.
1993
Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc
1991 StandoutScience
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
1995 Standout
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
The molecular role of Myc in growth and transformation: recent discoveries lead to new insights
1998
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
Cancer Cell Cycles
1996 StandoutScience
Histone Acetyltransferases
2001 Standout
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.
1993
Inhibition of c-fes expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiation.
1993
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems
2001 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted Polyamide
1991 StandoutScience
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene.
1992
Th1 and Th2 cytokines in mice with invasive aspergillosis
1997
Requirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal Transduction
1995 StandoutScience
A c- myb Antisense Oligodeoxynucleotide Inhibits Normal Human Hematopoiesis in Vitro
1988 Science
Induction of differentiation-associated changes in established human cells by infection with adeno-associated virus type 2
1992 StandoutNobel
Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway
2000
Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP
2000
Aspergillus fumigatusand Aspergillosis
1999 Standout
Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.
2001
Translating the Histone Code
2001 StandoutScience
The c-myc proto-oncogene regulates cardiac development in transgenic mice.
1990
Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.
1990
Sequence analysis of mouse vomeronasal receptor gene clusters reveals common promoter motifs and a history of recent expansion
2001 StandoutNobel
Role for c-myc in Activation-Induced Apoptotic Cell Death in T Cell Hybridomas
1992 Science
Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway
1998 StandoutNobel
Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors
2000
Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides.
1988
Regulation of the Ets-Related Transcription Factor Elf-1 by Binding to the Retinoblastoma Protein
1993 StandoutScienceNobel
The c-myc Proto-Oncogene Regulates Cardiac Development in Transgenic Mice
1990
Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles
2004 StandoutNobel
Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon
1993
Specific interaction of Aspergillus fumigatus with fibrinogen and its role in cell adhesion
1994
Transcription Factors, Normal Myeloid Development, and Leukemia
1997
Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients
1994
Works of Robert L. Redner being referenced
Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells.
1999
Improved quality of life for romiplostim‐treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo‐controlled trials
2008
Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide
1990
Patterns of Infection in Patients with Aplastic Anemia and the Emergence of Aspergillus As a Major Cause of Death
1992
Leukemia with distinct phenotypes in transgenic mice expressing PML/RARα, PLZF/RARα or NPM/RARα
2005
Effect of antacid on imatinib absorption
2008
NPM–RAR, not the RAR–NPM reciprocal t(5;17)(q35;q21) acute promyelocytic leukemia fusion protein, inhibits myeloid differentiation
2013
An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation.
1988
Chromatin Remodeling and Leukemia: New Therapeutic Paradigms
1999
Chromatin Remodeling and Leukemia: New Therapeutic Paradigms
1999
Overexpression of Wild-Type Retinoic Acid Receptor (RAR) Recapitulates Retinoic Acid-Sensitive Transformation of Primary Myeloid Progenitors by Acute Promyelocytic Leukemia RAR-Fusion Genes
1999
ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex
1998
An oligomer Complementary to c-myc mRNA Inhibits Proliferation of HL-60 Promyelocytic Cells and Induces Differentiation
1988
A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APML) with atypical features.
1994